Literature DB >> 3496151

Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.

L V Levin, T W Griffin, L R Childs, S Davis, D E Haagensen.   

Abstract

Anti-carcinoembryonic antigen (CEA) immunotoxins constructed with multiple anti-CEA antibodies (goat and baboon polyclonal, and three murine monoclonal antibodies) by covalently linking them to the A chain of ricin via a disulfide bond all function as potent and specific toxins for CEA-bearing cells, suggesting that the CEA molecule is capable of directing productive internalization of ricin A chain. The high potency of anti-CEA immunotoxins apparently makes addition of ricin B chain unnecessary for high toxic efficiency, as in some other systems, because presence of the B chain reduces target cell specificity. Several characteristics of the immunotoxins which might account for their cytotoxic potency were studied. Equilibrium association constants of the goat, baboon, and murine monoclonal C-19 antibodies with fluid-phase CEA were determined by using Langmuir plots and were found to be 8.79, 6.61, and 8.13 X 10(9) M-1, respectively, indicating the high and similar affinities of the three antibodies toward CEA. Radioimmunoassay binding studies of the three immunotoxins with 125I-CEA showed that the antibody portions of the molecules retained the ability to form complexes with CEA after conjugation to ricin A chain. The maximum number of anti-CEA antibody molecules bound per cell, as demonstrated by 111In-labeled C-19 binding assays with CEA-bearing cell lines, varied from 2.65 X 10(5) per cell for HT29 to 2.01 X 10(6) for LoVo, with an intermediate value of 1.17 X 10(6) per cell for WiDr. Cytotoxicity of the immunotoxins was assessed by inhibition of protein synthesis and expressed as a median inhibitory dose (ID50). Comparison of the ID50's of each immunotoxin on the three cell lines has shown that the immunotoxin made of the monoclonal C-19 antibody is in general 6 to 7 times more cytotoxic than the goat and baboon antibody immunotoxins. The affinity of CEA-antibody binding is probably an important, but not a sole factor in determining the immunotoxin potency. The fact that the antibodies with very similar affinity toward fluid phase CEA make immunotoxins of different potency might indicate that interactions with membrane-bound CEA are more complex and/or the efficiency of internalization of various immunotoxins is different. An important factor in immunotoxin action appears to be the CEA content in target adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496151     DOI: 10.1007/BF00205630

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  14 in total

1.  Proceedings: Interrelationship of carcinoembryonic antigen and colon carcinoma antigen-3.

Authors:  E S Newman; S E Petras; A Georgiadis; H J Hansen
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

2.  Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.

Authors:  R J Youle; D M Neville
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

3.  The kinetics of antibody binding to membrane antigens in solution and at the cell surface.

Authors:  D W Mason; A F Williams
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

Review 4.  Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.

Authors:  D M Neville; R J Youle
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.

Authors:  T W Griffin; L R Haynes; J A DeMartino
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

6.  The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method.

Authors:  D J Hnatowich; R L Childs; D Lanteigne; A Najafi
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.

Authors:  V Raso; J Ritz; M Basala; S F Schlossman
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

8.  Evaluation of baboon antiserum to carcinoembryonic antigen.

Authors:  D E Haagensen; C E Cox; W G Dilley; M Hensley; J Murdoch; E S Newman; S A Wells
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

9.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus.

Authors:  D J FitzGerald; I S Trowbridge; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 12.779

View more
  7 in total

Review 1.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

2.  Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.

Authors:  Christopher M Pirie; Benjamin J Hackel; Michael G Rosenblum; K Dane Wittrup
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

3.  Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.

Authors:  T Iwahashi; Y Tone; J Usui; H Watanabe; I Sugawara; S Mori; H Okazaki
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Internalization of an intact doxorubicin immunoconjugate.

Authors:  L B Shih; D M Goldenberg; H Xuan; H W Lu; M J Mattes; T C Hall
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

5.  Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.

Authors:  Joseph Ryan Polli; Ping Chen; Brandon M Bordeau; Joseph P Balthasar
Journal:  AAPS J       Date:  2022-03-25       Impact factor: 3.603

Review 6.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.

Authors:  Martin C Boonstra; Susanna W L de Geus; Hendrica A J M Prevoo; Lukas J A C Hawinkels; Cornelis J H van de Velde; Peter J K Kuppen; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Biomark Cancer       Date:  2016-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.